Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Vaccines
|
August 6, 2021
A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
Rémi Vernet, Emily Charrier, Julien Grogg, et al.
Vaccines
|
June 2, 2021
Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model
Rémi Vernet, Emily Charrier, Erika Cosset, et al.
Oncoimmunology
|
September 19, 2017
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies
Denis Migliorini, Nicolas Mach, Diego Aguiar, et al.
Cancer Research Communications
|
July 23, 2024
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, et al.
Human Molecular Genetics
|
August 8, 2013
A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1
Morgane Gauthier, Antoine Marteyn, Jérôme Alexandre Denis, et al.
Geroscience
|
August 7, 2024
Right anterior insula ASL hypoperfusion as a diagnostic biomarker of prodromal and mild dementia with Lewy bodies: preliminary evidence using a Bayesian approach
Golda Gommel, Ludovic Jeanjean-Dormegny, Clément de Crespin de Billy, et al.
BMC Biology
|
July 23, 2013
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors
Guanghua Yang, Karim Si-Tayeb, Sébastien Corbineau, et al.
Experimental Hematology & Oncology
|
August 31, 2025
Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial
Eugenio Fernandez, Rémi Vernet, Muriel Urwyler, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Vaccines
|
August 6, 2021
A Quantitative ELISA Protocol for Detection of Specific Human IgG against the SARS-CoV-2 Spike Protein
Rémi Vernet, Emily Charrier, Julien Grogg, et al.
Vaccines
|
June 2, 2021
Local Sustained GM-CSF Delivery by Genetically Engineered Encapsulated Cells Enhanced Both Cellular and Humoral SARS-CoV-2 Spike-Specific Immune Response in an Experimental Murine Spike DNA Vaccination Model
Rémi Vernet, Emily Charrier, Erika Cosset, et al.
Oncoimmunology
|
September 19, 2017
First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies
Denis Migliorini, Nicolas Mach, Diego Aguiar, et al.
Cancer Research Communications
|
July 23, 2024
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid Tumors
Rémi Vernet, Eugenio Fernandez, Denis Migliorini, et al.
Human Molecular Genetics
|
August 8, 2013
A defective Krab-domain zinc-finger transcription factor contributes to altered myogenesis in myotonic dystrophy type 1
Morgane Gauthier, Antoine Marteyn, Jérôme Alexandre Denis, et al.
Geroscience
|
August 7, 2024
Right anterior insula ASL hypoperfusion as a diagnostic biomarker of prodromal and mild dementia with Lewy bodies: preliminary evidence using a Bayesian approach
Golda Gommel, Ludovic Jeanjean-Dormegny, Clément de Crespin de Billy, et al.
BMC Biology
|
July 23, 2013
Integration-deficient lentivectors: an effective strategy to purify and differentiate human embryonic stem cell-derived hepatic progenitors
Guanghua Yang, Karim Si-Tayeb, Sébastien Corbineau, et al.
Experimental Hematology & Oncology
|
August 31, 2025
Overall survival of recurrent/metastatic head & neck squamous cell carcinoma patients progressing after ≥ 1 line of systemic therapy, treated with MVX-ONCO-1, a novel, first in class cell encapsulation-based immunotherapy: results of SAKK 11/16, a phase IIa trial
Eugenio Fernandez, Rémi Vernet, Muriel Urwyler, et al.
Page
of 1